Get the Stockscreener App
43.27
1.88%
0.80
After Hours:
43.27
Cg Oncology Inc stock is traded at $43.27, with a volume of 1.42M.
It is up +1.88% in the last 24 hours and up +7.42% over the past month.
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
See More
Previous Close:
$42.47
Open:
$42.31
24h Volume:
1.42M
Relative Volume:
1.54
Market Cap:
$3.30B
Revenue:
-
Net Income/Loss:
$-64.16M
P/E Ratio:
-34.07
EPS:
-1.2702
Net Cash Flow:
$-69.06M
1W Performance:
-0.92%
1M Performance:
+7.42%
6M Performance:
+60.62%
1Y Performance:
+21.78%
1-Day Range:
$41.04
$43.40
1-Week Range:
$41.04
$45.03
52-Week Range:
$14.80
$45.56
Cg Oncology Inc Stock (CGON) Company Profile
Name
Cg Oncology Inc
Sector
Industry
Phone
(949) 419-6203
Address
400 SPECTRUM CENTER DRIVE, IRVINE
Compare CGON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
43.27 | 3.24B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-25 | Initiated | Guggenheim | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Jul-10-25 | Resumed | Goldman | Buy |
| May-02-25 | Initiated | JP Morgan | Overweight |
| Apr-16-25 | Initiated | Scotiabank | Sector Perform |
| Jan-07-25 | Initiated | TD Cowen | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| Sep-23-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-28-24 | Initiated | ROTH MKM | Buy |
| Jun-28-24 | Initiated | BofA Securities | Buy |
| Feb-20-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-20-24 | Initiated | Goldman | Neutral |
| Feb-20-24 | Initiated | Morgan Stanley | Overweight |
| Feb-14-24 | Initiated | H.C. Wainwright | Buy |
View All
Cg Oncology Inc Stock (CGON) Latest News
Why CG Oncology Inc. stock is rated strong buyQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
How to forecast CG Oncology Inc. trends using time series2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Why retail investors favor CG Oncology Inc. stockDollar Strength & Long-Term Capital Growth Strategies - newser.com
Will CG Oncology Inc. stock recover faster than marketJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
What hedge fund activity signals for CG Oncology Inc. stockWeekly Investment Report & Growth Focused Stock Reports - newser.com
Why CG Oncology Inc. stock attracts global investors2025 Sector Review & Precise Swing Trade Alerts - newser.com
Will CG Oncology Inc. stock deliver consistent dividendsJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
Is CG Oncology Inc. reversing from oversold territoryJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
How CG Oncology Inc. stock reacts to inflationary pressuresJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - newser.com
Will CG Oncology Inc. stock remain a Wall Street favoriteSell Signal & Weekly Return Optimization Alerts - newser.com
Market reaction to CG Oncology Inc.’s recent newsTrade Exit Report & Verified Short-Term Trading Plans - newser.com
What the charts say about CG Oncology Inc. todayPortfolio Return Report & Low Drawdown Trading Techniques - newser.com
Sentiment analysis tools applied to CG Oncology Inc.Weekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Identifying reversal signals in CG Oncology Inc.Earnings Beat & High Accuracy Swing Entry Alerts - newser.com
CG Oncology, Inc. (CGON) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
CG Oncology Inc Stock Analysis and ForecastMACD Histogram Signals & Discover High-Return Stocks Before They Boom - earlytimes.in
Advanced analytics toolkit walkthrough for CG Oncology Inc.Quarterly Portfolio Summary & High Accuracy Buy Signal Tips - newser.com
CG Oncology (NASDAQ:CGON) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Is CG Oncology Inc. stock a dividend growth opportunityWeekly Stock Report & AI Optimized Trading Strategy Guides - Fundação Cultural do Pará
Why CG Oncology, Inc. (CGON) Surged on Monday - MSN
Cg Oncology Inc Stock (CGON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):